Taylor Asset Management’s Can-Fite BioPharma American Depositary Shares CANF Stock Holding History

Taylor Asset Management’s Portfolio CANF Stock Details CANF Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q1	$471K	Sell	180 -86	-32%	-$300K	0.31%	17
2018 Q4	$1M	Hold	266	–	–	0.67%	15
2018 Q3	$1.03M	Hold	266	–	–	0.47%	17
2018 Q2	$940K	Hold	266	–	–	0.44%	16
2018 Q1	$1.06M	Hold	266	–	–	0.46%	16
2017 Q4	$1.19M	Hold	266	–	–	0.41%	16
2017 Q3	$1.35M	Hold	266	–	–	0.43%	17
2017 Q2	$1.43M	Hold	266	–	–	0.47%	17
2017 Q1	$1.53M	Hold	266	–	–	0.45%	20
2016 Q4	$1.9M	Hold	266	–	–	0.55%	19
2016 Q3	$2.11M	Buy	266 +56	+27%	+$390K	0.62%	21
2016 Q2	$1.61M	Buy	210 +26	+14%	+$220K	0.46%	20
2016 Q1	$1.54M	Sell	184 -5	-3%	-$34.6K	0.4%	22
2015 Q4	$1.66M	Buy	189 +27	+17%	+$272K	0.4%	23
2015 Q3	$2.01M	Buy	162 +46	+40%	+$309K	0.43%	23
2015 Q2	$763K	Buy	116 +110	+1,833%	+$770K	0.14%	24
2015 Q1	$42K	Buy	+6	New	+$72.1K	0.01%	36

Other funds holding CANF

MIH

Meitav Investment House Bene-Beraq, Israel $14.9B AUM 46.8% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

RJA

Raymond James & Associates St Petersburg, Florida $164B AUM 33.91% 1-Year Est. Return

FDCDDQ

Federation des caisses Desjardins du Quebec Levis, Quebec, Canada $27.8B AUM 31.66% 1-Year Est. Return

Advisornet Financial Minnetonka, Minnesota $2.19B AUM 21.28% 1-Year Est. Return

Bank of Montreal Toronto, Ontario, Canada $269B AUM 31.4% 1-Year Est. Return

Taylor Asset Management's CANF Position: Q1 2019 in Review

Taylor Asset Management reduced its Can-Fite BioPharma American Depositary Shares (CANF) stake by 32% in Q1 2019, selling an estimated $300K and leaving 180 shares worth $471K. The position accounts for 0.31% of the portfolio, ranked #17.

Taylor Asset Management first reported a position in CANF in Q1 2015 and has held it in 17 quarters since. The position peaked at $2.11M in Q3 2016. 6 funds tracked by Wall St. Rank hold CANF as of Q1 2019.

Taylor Asset Management held 180 shares of Can-Fite BioPharma American Depositary Shares worth $471K as of Q1 2019.
Taylor Asset Management sold 86 Can-Fite BioPharma American Depositary Shares shares in Q1 2019, an estimated $300K.
Can-Fite BioPharma American Depositary Shares made up 0.31% of Taylor Asset Management's portfolio in Q1 2019, its #17 holding.
Taylor Asset Management first reported a position in Can-Fite BioPharma American Depositary Shares in Q1 2015 and has held it in 17 quarters since.
Taylor Asset Management's Can-Fite BioPharma American Depositary Shares position peaked at $2.11M in Q3 2016.
6 funds tracked by Wall St. Rank held Can-Fite BioPharma American Depositary Shares as of Q1 2019.

Based on Taylor Asset Management's 13F filing for Q1 2019, filed 14 May 2019.